Isomorphic Labs reportedly raising funds at up to $50B valuation

Alphabet spinoff Isomorphic Labs is reportedly in early-stage talks to raise a new funding round at a valuation of $40 billion to $50 billion, according to Bloomberg, which did not specify the round's size.

Isomorphic's flagship AI platform, IsoDDE, is designed to automate binding pocket discovery, which it says is more than 50% better than the closest competing tool, and it models antibody interactions about 2.3 times better than AlphaFold.

The company earns revenue through research partnerships with Eli Lilly, Novartis and Johnson & Johnson.